Jiang Xi Sanxin Medtec Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001ZJ1
CNY
9.15
-0.01 (-0.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Jiang Xi Sanxin Medtec Co., Ltd.
Why is Jiang Xi Sanxin Medtec Co., Ltd. ?
1
With ROE of 19.58%, it has a very attractive valuation with a 2.46 Price to Book Value
  • Over the past year, while the stock has generated a return of 19.30%, its profits have risen by 11.6% ; the PEG ratio of the company is 1.1
  • At the current price, the company has a high dividend yield of 4.7
2
Market Beating performance in long term as well as near term
  • Along with generating 19.30% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Jiang Xi Sanxin Medtec Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jiang Xi Sanxin Medtec Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Jiang Xi Sanxin Medtec Co., Ltd.
5.9%
1.21
35.30%
China Shanghai Composite
14.77%
1.01
15.10%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.61%
EBIT Growth (5y)
18.50%
EBIT to Interest (avg)
71.65
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.87
Tax Ratio
10.16%
Dividend Payout Ratio
67.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.45%
ROE (avg)
18.36%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
2.46
EV to EBIT
12.27
EV to EBITDA
8.60
EV to Capital Employed
2.58
EV to Sales
2.05
PEG Ratio
1.09
Dividend Yield
4.68%
ROCE (Latest)
21.06%
ROE (Latest)
19.58%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 455.19 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 5.35%

DEBTORS TURNOVER RATIO(HY)

Highest at 15.13%

RAW MATERIAL COST(Y)

Fallen by 1.46% (YoY

CASH AND EQV(HY)

Highest at CNY 981.56 MM

OPERATING PROFIT(Q)

Highest at CNY 99.15 MM

-2What is not working for the Company
INTEREST(Q)

At CNY 1.06 MM has Grown at 143.5%

Here's what is working for Jiang Xi Sanxin Medtec Co., Ltd.
Inventory Turnover Ratio
Highest at 5.35% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 15.13% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Operating Cash Flow
Highest at CNY 455.19 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Operating Profit
Highest at CNY 99.15 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Cash and Eqv
Highest at CNY 981.56 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 1.46% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiang Xi Sanxin Medtec Co., Ltd.
Interest
At CNY 1.06 MM has Grown at 143.5%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)